A study published in Nature found that how people share clinical trial information differs sharply between Bluesky and X, with platform-specific communication patterns affecting the accessibility and cohesion of research-related discourse. The analysis reported that Bluesky conversations were more research-focused and cohesive, while X posts were more fragmented and event-driven. The authors said sponsors and CROs could use the differences to tailor recruitment and patient communication, while emphasizing that accuracy of online information remains a shared responsibility across companies, clinicians, and platforms.